Skip to content

CALMARE THERAPEUTICS INC: 10-Q filed 2016-03-01

What CALMARE THERAPEUTICS INC reported in its quarterly report filed 2016-03-01 (fiscal Q3 2015): 27 published measures, 76 facts as tagged in accession 0001615774-16-004352.

This filing

Form
10-Q (quarterly report)
Filed
2016-03-01
Fiscal period
fiscal Q3 2015
Accession
0001615774-16-004352 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All CALMARE THERAPEUTICS INC filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2015-09-304,230,467USD
At 2014-12-314,430,026USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2015-09-30-9,662,748USD
At 2014-12-31-7,738,346USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2015-07-01 to 2015-09-30-1,062,802USD92
2015-01-01 to 2015-09-30-2,845,813USD273
2014-07-01 to 2014-09-30-1,229,112USD92
2014-01-01 to 2014-09-30-2,746,267USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2015-01-01 to 2015-09-304,700USD273
2014-01-01 to 2014-09-3047,688USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2015-09-30-58,538,780USD
At 2014-12-31-55,692,967USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2015-07-01 to 2015-09-3028,370,953shares92
2015-01-01 to 2015-09-3027,673,151shares273
2014-07-01 to 2014-09-3024,974,613shares92
2014-01-01 to 2014-09-3022,715,940shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2015-07-01 to 2015-09-3028,370,953shares92
2015-01-01 to 2015-09-3027,673,151shares273
2014-07-01 to 2014-09-3024,974,613shares92
2014-01-01 to 2014-09-3022,715,940shares273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2015-09-3028,073USD
At 2014-12-3135,640USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2015-01-01 to 2015-09-3049,181USD273
2014-01-01 to 2014-09-3049,185USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2015-07-01 to 2015-09-30-731,650USD92
2015-01-01 to 2015-09-30-2,110,639USD273
2014-07-01 to 2014-09-30-581,141USD92
2014-01-01 to 2014-09-30-1,658,198USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2015-09-304,187,394USD
At 2014-12-314,379,386USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2015-07-01 to 2015-09-30300,361USD92
2015-01-01 to 2015-09-30690,892USD273
2014-07-01 to 2014-09-30574,840USD92
2014-01-01 to 2014-09-30792,520USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2015-09-3013,828,111USD
At 2014-12-3112,111,713USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2015-09-301,545,804USD
At 2014-12-311,346,138USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2015-07-01 to 2015-09-30885,086USD92
2015-01-01 to 2015-09-302,453,966USD273
2014-07-01 to 2014-09-30767,942USD92
2014-01-01 to 2014-09-302,236,138USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2015-09-304,078,220USD
At 2014-12-314,118,220USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2015-07-01 to 2015-09-30137,374USD92
2015-01-01 to 2015-09-30297,084USD273
2014-07-01 to 2014-09-30152,816USD92
2014-01-01 to 2014-09-30521,530USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2015-09-3028,395,888shares
At 2014-12-3125,908,978shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2015-09-3048,531,399USD
At 2014-12-3147,634,857USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2015-09-30220,191USD
At 2014-12-31215,491USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2015-09-30192,118USD
At 2014-12-31179,851USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2015-09-3061,853USD
At 2014-12-31253,102USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2015-07-01 to 2015-09-30-1,062,802USD92
2015-01-01 to 2015-09-30-2,845,813USD273
2014-07-01 to 2014-09-30-1,229,112USD92
2014-01-01 to 2014-09-30-2,746,267USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2015-07-01 to 2015-09-30362,208USD92
2015-01-01 to 2015-09-301,012,369USD273
2014-07-01 to 2014-09-30432,528USD92
2014-01-01 to 2014-09-30943,554USD273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2015-07-01 to 2015-09-303,904USD92
2015-01-01 to 2015-09-3012,267USD273
2014-07-01 to 2014-09-305,630USD92
2014-01-01 to 2014-09-3011,976USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2015-07-01 to 2015-09-30-331,152USD92
2015-01-01 to 2015-09-30-735,174USD273
2014-07-01 to 2014-09-30-647,971USD92
2014-01-01 to 2014-09-30-1,088,069USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2015-01-01 to 2015-09-30-40,000USD273
2014-01-01 to 2014-09-30-150,000USD273

Inspect the source

Entity
CALMARE THERAPEUTICS INC / CIK 0000102198
Captured
SEC response SHA-256
0ebcc84665a429c0cdf4445786085ba38ea38f61d1d9b78a273e6ff2088597c3

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000102198.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))